Document is current

Any future updates will be listed below

MS drug beneficial in an underrepresented group

Crossref DOI link: https://doi.org/10.1038/s41582-025-01060-3

Published Online: 2025-01-17

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark